SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001144204-14-042335
Filing Date
2014-07-10
Accepted
2014-07-10 16:45:43
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-1 v383129_s1.htm S-1 2217251
2 EXHIBIT 5.1 v383129_ex5-1.htm EX-5.1 6976
3 EXHIBIT 10.44 v383129_ex10-44.htm EX-10.44 25317
4 EXHIBIT 23.1 v383129_ex23-1.htm EX-23.1 3540
5 EXHIBIT 23.2 v383129_ex23-2.htm EX-23.2 5262
6 GRAPHIC tlogo.jpg GRAPHIC 13471
7 GRAPHIC tfooter.jpg GRAPHIC 85027
8 GRAPHIC tlogo1.jpg GRAPHIC 6457
  Complete submission text file 0001144204-14-042335.txt   12125942

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT bcli-20140331.xml EX-101.INS 1914916
10 XBRL TAXONOMY EXTENSION SCHEMA bcli-20140331.xsd EX-101.SCH 91576
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20140331_cal.xml EX-101.CAL 41167
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20140331_def.xml EX-101.DEF 353376
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20140331_lab.xml EX-101.LAB 505676
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20140331_pre.xml EX-101.PRE 415260
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-197347 | Film No.: 14970024
SIC: 2836 Biological Products, (No Diagnostic Substances)